This inventor holds 5 USPTO granted patents. Top assignees: University of California, Cortex Pharmaceuticals, Inc.. Active years: 1999-2010.
Company Filing History:
Years Active: 1999-2010
Title: Christopher M Marrs: Innovator in Neuropharmacology
Introduction
Christopher M Marrs is a notable inventor based in Foothill Ranch, CA (US). He has made significant contributions to the field of neuropharmacology, holding a total of 5 patents. His work primarily focuses on enhancing cognitive abilities and addressing various neurological disorders.
Latest Patents
Marrs' latest patents include innovative compounds aimed at improving synaptic responses in the brain. One of his key inventions is related to carbonylbenzoxazine compounds, which are designed for the prevention and treatment of cerebral insufficiency. This invention enhances receptor functioning in synapses responsible for higher-order behaviors, particularly in relation to cognitive abilities affected by memory impairment. These compounds are particularly relevant for conditions such as dementia and disorders like Parkinson's disease and schizophrenia.
Another significant patent involves benzofurazan compounds that enhance AMPA receptor activity. These compounds are shown to facilitate the learning of behaviors dependent on AMPA receptors and can be used to treat memory impairment. They also aim to restore imbalances in excitatory synaptic activity, which is crucial for addressing conditions like schizophrenia.
Career Highlights
Throughout his career, Marrs has worked with esteemed institutions such as the University of California and Cortex Pharmaceuticals, Inc. His research has contributed to advancements in therapeutic approaches for cognitive disorders.
Collaborations
Marrs has collaborated with notable professionals in his field, including Gary A Rogers and Matthew Allan. Their combined expertise has furthered the development of innovative solutions in neuropharmacology.
Conclusion
Christopher M Marrs stands out as a significant figure in the realm of neuropharmacology, with a focus on enhancing cognitive functions and addressing neurological disorders through his innovative patents. His contributions continue to impact the field positively.